Snake Bites Clinical Trial
Official title:
Low Dose Adrenaline, Promethazine, & Hydrocortisone (Alone and in Combination) to Prevent Acute Adverse Reactions to Antivenom in People Bitten by Snakes: Randomised, Double Blind, Placebo-Controlled Trial
A study to increase the safety of polyvalent antivenom involving 1000 patients in three centres: low dose adrenaline, promethazine, & hydrocortisone (alone and in combination) to prevent acute adverse reactions to antivenom in people bitten by snakes: randomised, double blind, placebo-controlled trial.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03326492 -
Evaluation of Anti-venoms Serum in Africa
|
||
Terminated |
NCT02570347 -
Routine Antibiotic vs. Directed Antibiotic Treatment in Snake Bite
|
Phase 4 | |
Completed |
NCT03890016 -
Study Comparing Modified Lee White Clotting Time Against Twenty Minute Whole Blood Clotting Test in Snakebite Victims
|
||
Withdrawn |
NCT02694952 -
Non-inferiority Trial of Two Snake Antivenoms in CAR (PAVES)
|
N/A | |
Completed |
NCT04520282 -
Hemostatic Variables In Snakebite Study
|
||
Completed |
NCT01864200 -
Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation
|
Phase 4 | |
Completed |
NCT04470791 -
Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom.
|
N/A |